CD33 (Siglec-3) Inhibitory Function: Role in the NKG2D/DAP10 Activating Pathway
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD33 (Siglec-3) Inhibitory Function: Role in the NKG2D/DAP10 Activating Pathway
Authors
Keywords
-
Journal
Journal of Immunology Research
Volume 2019, Issue -, Pages 1-15
Publisher
Hindawi Limited
Online
2019-04-16
DOI
10.1155/2019/6032141
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease
- (2018) Ana Stojanovic et al. Frontiers in Immunology
- Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset
- (2017) Stephan Kloess et al. Frontiers in Immunology
- Evidence for C1q-mediated crosslinking of CD33/LAIR-1 inhibitory immunoreceptors and biological control of CD33/LAIR-1 expression
- (2017) Myoungsun Son et al. Scientific Reports
- MHC-I Molecules Selectively Inhibit Cell-Mediated Cytotoxicity Triggered by ITAM-Coupled Activating Receptors and 2B4
- (2014) Rubén Corral-San Miguel et al. PLoS One
- NK cell-based immunotherapy for malignant diseases
- (2013) Min Cheng et al. Cellular & Molecular Immunology
- Organ-specific phenotypic and functional features of NK cells in humans
- (2013) Richa Sharma et al. IMMUNOLOGIC RESEARCH
- Splicing defect of CD33 and inflammatory syndrome associated with occult bacterial infection
- (2013) Maria L. Balmer et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology
- (2013) Elizabeth M Bradshaw et al. NATURE NEUROSCIENCE
- Siglecs and Immune Regulation
- (2012) Shiv Pillai et al. Annual Review of Immunology
- High glucose concentrations induce TNF-α production through the down-regulation of CD33 in primary human monocytes
- (2012) Yolanda Gonzalez et al. BMC IMMUNOLOGY
- Defining Early Human NK Cell Developmental Stages in Primary and Secondary Lymphoid Tissues
- (2012) Diana N. Eissens et al. PLoS One
- Cytotoxicity of CD56bright NK Cells towards Autologous Activated CD4+ T Cells Is Mediated through NKG2D, LFA-1 and TRAIL and Dampened via CD94/NKG2A
- (2012) Natasja Nielsen et al. PLoS One
- Epitope mapping, expression and post-translational modifications of two isoforms of CD33 (CD33M and CD33m) on lymphoid and myeloid human cells
- (2011) A. B. Perez-Oliva et al. GLYCOBIOLOGY
- CD56brightCD16+ NK Cells: A Functional Intermediate Stage of NK Cell Differentiation
- (2011) V. Beziat et al. JOURNAL OF IMMUNOLOGY
- Integration of Activating and Inhibitory Receptor Signaling by Regulated Phosphorylation of Vav1 in Immune Cells
- (2011) S. Mesecke et al. Science Signaling
- Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
- (2009) H. Fujisaki et al. CANCER RESEARCH
- Colocalization of the IL-12 receptor and Fc RIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-
- (2008) S. V. Kondadasula et al. BLOOD
- Up on the tightrope: natural killer cell activation and inhibition
- (2008) Lewis L Lanier NATURE IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started